Search

Keli L. Hill

Examiner (ID: 14362, Phone: (571)272-4375 , Office: P/2912 )

Most Active Art Unit
2912
Art Unit(s)
2912, 2922, 2952
Total Applications
3649
Issued Applications
3514
Pending Applications
12
Abandoned Applications
123

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5997022 [patent_doc_number] => 20110016537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Cellular model of tauopathies for lead identification and drug discovery' [patent_app_type] => utility [patent_app_number] => 10/571934 [patent_app_country] => US [patent_app_date] => 2004-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22167 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20110016537.pdf [firstpage_image] =>[orig_patent_app_number] => 10571934 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/571934
Cellular model of tauopathies for lead identification and drug discovery Sep 15, 2004 Abandoned
Array ( [id] => 7142784 [patent_doc_number] => 20050118172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'CDw52-specific antibody for treatment of multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 10/938874 [patent_app_country] => US [patent_app_date] => 2004-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1830 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118172.pdf [firstpage_image] =>[orig_patent_app_number] => 10938874 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/938874
CDw52-specific antibody for treatment of multiple sclerosis Sep 12, 2004 Abandoned
Array ( [id] => 463134 [patent_doc_number] => 07238529 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Methods and compositions for treating ocular disorders' [patent_app_type] => utility [patent_app_number] => 10/933684 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3933 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238529.pdf [firstpage_image] =>[orig_patent_app_number] => 10933684 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/933684
Methods and compositions for treating ocular disorders Sep 2, 2004 Issued
Array ( [id] => 7127853 [patent_doc_number] => 20050059597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Method of reducing injury to mammalian cells' [patent_app_type] => utility [patent_app_number] => 10/930192 [patent_app_country] => US [patent_app_date] => 2004-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 62 [patent_no_of_words] => 29449 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059597.pdf [firstpage_image] =>[orig_patent_app_number] => 10930192 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/930192
Method of screening peptides useful in treating traumatic injury to the brain or spinal cord Aug 30, 2004 Issued
Array ( [id] => 6939723 [patent_doc_number] => 20050113286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Methods for treating congestive heart failure' [patent_app_type] => utility [patent_app_number] => 10/931498 [patent_app_country] => US [patent_app_date] => 2004-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11348 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113286.pdf [firstpage_image] =>[orig_patent_app_number] => 10931498 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/931498
Methods for treating congestive heart failure Aug 30, 2004 Abandoned
Array ( [id] => 7074720 [patent_doc_number] => 20050147988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'H. pylori FlbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori FlbA polypeptides, and compositions for detection of an infection comprising H. pylori FlbA polypeptides' [patent_app_type] => utility [patent_app_number] => 10/926270 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15978 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147988.pdf [firstpage_image] =>[orig_patent_app_number] => 10926270 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/926270
H. pylori FlbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori FlbA polypeptides, and compositions for detection of an infection comprising H. pylori FlbA polypeptides Aug 25, 2004 Abandoned
Array ( [id] => 5501675 [patent_doc_number] => 20090162363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'PEDF-R RECEPTOR AND USES' [patent_app_type] => utility [patent_app_number] => 10/566540 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 52834 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162363.pdf [firstpage_image] =>[orig_patent_app_number] => 10566540 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/566540
PEDF-R RECEPTOR AND USES Aug 4, 2004 Abandoned
Array ( [id] => 7353279 [patent_doc_number] => 20040249128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Molecules for disease detection and treatment' [patent_app_type] => new [patent_app_number] => 10/483512 [patent_app_country] => US [patent_app_date] => 2004-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63492 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20040249128.pdf [firstpage_image] =>[orig_patent_app_number] => 10483512 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/483512
Molecules for disease detection and treatment Jul 18, 2004 Abandoned
Array ( [id] => 5241738 [patent_doc_number] => 20070020230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Use of chemokines, and pharmaceutical preparations containing the same' [patent_app_type] => utility [patent_app_number] => 10/565226 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5955 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020230.pdf [firstpage_image] =>[orig_patent_app_number] => 10565226 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/565226
Use of chemokines, and pharmaceutical preparations containing the same Jul 8, 2004 Abandoned
Array ( [id] => 7275645 [patent_doc_number] => 20040235096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Method for regulating dopamine producing cells' [patent_app_type] => new [patent_app_number] => 10/487176 [patent_app_country] => US [patent_app_date] => 2004-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5914 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235096.pdf [firstpage_image] =>[orig_patent_app_number] => 10487176 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/487176
Method for regulating dopamine producing cells Jul 5, 2004 Abandoned
Array ( [id] => 7328573 [patent_doc_number] => 20040253683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Cryptopain compositions for prophylaxis, treatment, diagnosis and detection of cryptosporidium species' [patent_app_type] => new [patent_app_number] => 10/867888 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12245 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253683.pdf [firstpage_image] =>[orig_patent_app_number] => 10867888 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/867888
Cryptopain compositions for prophylaxis, treatment, diagnosis and detection of cryptosporidium species Jun 13, 2004 Abandoned
Array ( [id] => 7329786 [patent_doc_number] => 20040254114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Polynucleotides encoding truncated glial cell line-derived neurotrophic factor' [patent_app_type] => new [patent_app_number] => 10/855820 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22865 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20040254114.pdf [firstpage_image] =>[orig_patent_app_number] => 10855820 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855820
Polynucleotides encoding truncated glial cell line-derived neurotrophic factor May 25, 2004 Issued
Array ( [id] => 7276288 [patent_doc_number] => 20040235739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Neuroprotective methods and reagents' [patent_app_type] => new [patent_app_number] => 10/849704 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26357 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235739.pdf [firstpage_image] =>[orig_patent_app_number] => 10849704 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/849704
Neuroprotective methods and reagents May 18, 2004 Abandoned
Array ( [id] => 6990902 [patent_doc_number] => 20050089939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer\'s disease pathology' [patent_app_type] => utility [patent_app_number] => 10/842212 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15619 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089939.pdf [firstpage_image] =>[orig_patent_app_number] => 10842212 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/842212
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology May 9, 2004 Abandoned
Array ( [id] => 7348070 [patent_doc_number] => 20040192889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof' [patent_app_type] => new [patent_app_number] => 10/472812 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14284 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192889.pdf [firstpage_image] =>[orig_patent_app_number] => 10472812 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/472812
Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof May 5, 2004 Abandoned
Array ( [id] => 170397 [patent_doc_number] => 07662620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Human and mammalian stem cell-derived neuron survival factors' [patent_app_type] => utility [patent_app_number] => 10/833108 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 17 [patent_no_of_words] => 8763 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662620.pdf [firstpage_image] =>[orig_patent_app_number] => 10833108 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/833108
Human and mammalian stem cell-derived neuron survival factors Apr 27, 2004 Issued
Array ( [id] => 7211766 [patent_doc_number] => 20050054040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Novel human semaphorin homologs and polynucleotides encoding the same' [patent_app_type] => utility [patent_app_number] => 10/833509 [patent_app_country] => US [patent_app_date] => 2004-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8860 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054040.pdf [firstpage_image] =>[orig_patent_app_number] => 10833509 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/833509
Human semaphorin homologs and polynucleotides encoding the same Apr 27, 2004 Issued
Array ( [id] => 7404747 [patent_doc_number] => 20040175691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Use of the KCNQ2 and KCNQ3 genes for the discovery of agents useful in the treatment of neurological disorders' [patent_app_type] => new [patent_app_number] => 10/820307 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9340 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20040175691.pdf [firstpage_image] =>[orig_patent_app_number] => 10820307 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/820307
Use of the KCNQ2 and KCNQ3 genes for the discovery of agents useful in the treatment of neurological disorders Apr 7, 2004 Abandoned
Array ( [id] => 7263662 [patent_doc_number] => 20040241762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Assessing neuronal damage from blood samples' [patent_app_type] => new [patent_app_number] => 10/810388 [patent_app_country] => US [patent_app_date] => 2004-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6568 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241762.pdf [firstpage_image] =>[orig_patent_app_number] => 10810388 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810388
Assessing neuronal damage from blood samples Mar 25, 2004 Abandoned
Array ( [id] => 5662086 [patent_doc_number] => 20060252682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Liquid growth hormone formulation and process of preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/549763 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14889 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252682.pdf [firstpage_image] =>[orig_patent_app_number] => 10549763 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/549763
Liquid growth hormone formulation and process of preparation thereof Mar 10, 2004 Abandoned
Menu